ALLO ALLOGENE THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 16 analyst firms say about ALLOGENE THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
15 rated views · 16 analyst/firm records · 16 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 6 reports on ALLO from 6 analyst firms in the last 90 days (17 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Citizens lowered its target from $8.00 (set 14 Apr 2026) to $6.00 on 17 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | William Pickering | Hold | 14 Apr 2026 | 3.85 USD |
| Baird | Jack K Allen | Buy | 2 Aug 2026 | 9.00 USD |
| Canaccord Genuity | John Newman | Buy | 13 Mar 2026 | 14.00 USD |
| Citigroup | Samantha Semenkow | Buy | 14 Apr 2026 | 4.00 USD |
| Citizens JMP | Reni Benjamin | Buy | 17 Aug 2026 | 6.00 USD |
| H.C. Wainwright | Robert Burns | Buy | 14 Apr 2026 | Conflicting reports · excluded |
| Jefferies | Roger Song | Buy | 13 Apr 2026 | 10.00 USD |
| JPMorgan | Brian Cheng | Hold | 16 Apr 2026 | — |
| Piper Sandler | Biren Amin | Buy | 12 Aug 2026 | 8.00 USD · 13 Mar 2026 |
| RBC Capital Markets | Luca Issi | Buy | 13 Aug 2026 | 9.00 USD |
| TD Cowen | Tyler Van Buren | Buy | 15 Jun 2026 | — |
| Truist | Unnamed analyst | Buy | 25 Mar 2026 | — |
| UBS | Michael J Yee | Buy | 13 Aug 2026 | 8.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Oct 2026 | — |
| William Blair | Matt Phipps | Buy | 23 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 2.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:07 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.